Therachon's Series A Round

Therachon raised a round of funding on September 30, 2015.

Therachon is a global biotechnology company focused on developing treatments for rare, genetic diseases that currently have no available treatments. The company's lead pipeline candidate, TA-46, is a …

Articles about Therachon's Series A Round: